What now for aspirin and cancer prevention?

被引：12

作者：

Baron, JA ^{[1
]}

机构：

[1] Dartmouth Coll Sch Med, Dept Med, Lebanon, NH 03756 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 01期

关键词：

D O I：

10.1093/jnci/djh027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4 / 5

页数：2

共 26 条

[1]

Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168

[2] Pancreatic cancer biology and genetics [J].

Bardeesy, N ;

DePinho, RA .

NATURE REVIEWS CANCER, 2002, 2 (12) :897-909

[3]

Baron JA, 2003, PROG EXP TUMOR RES, V37, P1

[4] A randomized trial of aspirin to prevent colorectal adenomas [J].

Baron, JA ;

Cole, BF ;

Sandler, RS ;

Haile, RW ;

Ahnen, D ;

Bresalier, R ;

McKeown-Eyssen, G ;

Summers, RW ;

Rothstein, R ;

Burke, CA ;

Snover, DC ;

Church, TR ;

Allen, JI ;

Beach, M ;

Beck, GJ ;

Bond, JH ;

Byers, T ;

Greenberg, ER ;

Mandel, JS ;

Marcon, N ;

Mott, LA ;

Pearson, L ;

Saibil, F ;

van Stolk, RU .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899

[5] Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial [J].

Benamouzig, R ;

Deyra, J ;

Martin, A ;

Girard, B ;

Jullian, E ;

Piednoir, B ;

Couturier, D ;

Coste, T ;

Little, J ;

Chaussade, S .

GASTROENTEROLOGY, 2003, 125 (02) :328-336

[6]

Coogan PF, 2000, CANCER EPIDEM BIOMAR, V9, P119

[7] TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS [J].

GIARDIELLO, FM ;

HAMILTON, SR ;

KRUSH, AJ ;

PIANTADOSI, S ;

HYLIND, LM ;

CELANO, P ;

BOOKER, SV ;

ROBINSON, CR ;

OFFERHAUS, GJA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1313-1316

[8] Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum:: a meta-analysis -: art. no. 28 [J].

González-Pérez, A ;

Rodríguez, LAG ;

López-Ridaura, R .

BMC CANCER, 2003, 3 (1)

[9] Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force [J].

Hayden, M ;

Pignone, M ;

Phillips, C ;

Mulrow, C .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) :161-172

[10] Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers [J].

Hopper, JL ;

Baron, JA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :1010-1011

← 1 2 3 →